These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3074642)

  • 1. Biocompatibility of haemodialysis membranes.
    van Berlo A; Ellens DJ
    Adv Exp Med Biol; 1988; 238():341-58. PubMed ID: 3074642
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative and qualitative assessment and clinical meaning of molecules removed with BK membranes.
    Buoncristiani U; Galli F; Benedetti S; Errico R; Beninati S; Ghibelli L; Floridi A; Canestrari F
    Contrib Nephrol; 1999; 125():133-58. PubMed ID: 9895437
    [No Abstract]   [Full Text] [Related]  

  • 3. Biocompatibility of a new high-permeability modified cellulose membrane for haemodialysis.
    Ward RA; Schaefer RM; Falkenhagen D; Joshua MS; Heidland A; Klinkmann H; Gurland HJ
    Nephrol Dial Transplant; 1993; 8(1):47-53. PubMed ID: 8381935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
    Vanholder RC; Ringoir SM
    Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of haemodialysis on coagulation and platelets: are we measuring membrane biocompatibility?
    Ward RA
    Nephrol Dial Transplant; 1995; 10 Suppl 10():12-17. PubMed ID: 8825427
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of dialysis membrane on serum beta 2-microglobulin (beta 2M) in chronic haemodialysis patients.
    Farrell J; Bastani B
    Nephrol Dial Transplant; 1997 Apr; 12(4):856. PubMed ID: 9141041
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of the primary and repeated use of dialyzers with different membranes on the degree of dialysis-induced leukopenia].
    Strokov AG; Baeva LB; Levitskiĭ ER
    Med Tekh; 1990; (5):16-8. PubMed ID: 2273963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodialysis leucopenia as an index of membrane biocompatibility.
    Aljama P; Garin JM; Torres A; Martin-Malo A; Moreno E; Perez-Calderon R
    Contrib Nephrol; 1984; 37():129-33. PubMed ID: 6713865
    [No Abstract]   [Full Text] [Related]  

  • 9. Biocompatibility criteria in hemodialysis.
    Cordonnier DJ; Forêt M
    Contrib Nephrol; 1989; 71():30-5. PubMed ID: 2680263
    [No Abstract]   [Full Text] [Related]  

  • 10. High-efficiency dialysis with PMMA dialyzers: treatment dose delivery and long-term results.
    David S; Cambi V
    Contrib Nephrol; 1999; 125():96-110. PubMed ID: 9895434
    [No Abstract]   [Full Text] [Related]  

  • 11. KHA-CARI guideline: dialysis adequacy (haemodialysis): dialysis membranes.
    Kerr PG; Toussaint ND; ;
    Nephrology (Carlton); 2013 Jul; 18(7):485-8. PubMed ID: 23672488
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodialysis-related bioincompatibility and adhesion molecules.
    Dhondt A; Vanholder R; Lameire N
    Int J Artif Organs; 1998 Sep; 21(9):501-5. PubMed ID: 9828053
    [No Abstract]   [Full Text] [Related]  

  • 13. Focusing on membranes.
    von Sengbusch G; Bowry S; Vienken J
    Artif Organs; 1993 Apr; 17(4):244-53. PubMed ID: 8498904
    [No Abstract]   [Full Text] [Related]  

  • 14. Dilemma of membrane biocompatibility and reuse.
    Klinkmann H; Grassmann A; Vienken J
    Artif Organs; 1996 May; 20(5):426-32. PubMed ID: 8725623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyethersulfone as a high-performance membrane.
    Krieter DH; Lemke HD
    Contrib Nephrol; 2011; 173():130-136. PubMed ID: 21865785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialyzer permeability for low-molecular-weight proteins. Comparison between polysulfone, polyamide and cuprammonium-rayon dialyzers.
    Nensel U; Röckel A; Hillenbrand T; Bartel J
    Blood Purif; 1994; 12(2):128-34. PubMed ID: 7530014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatibility: is it a relevant consideration for today's haemodialysis?
    Shaldon S; Vienken J
    Int J Artif Organs; 1996 Apr; 19(4):201-14. PubMed ID: 8786170
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of a new polyamide membrane (Polyflux 130) in high-flux dialysis.
    Schaefer RM; Gilge U; Goehl H; Heidland A
    Blood Purif; 1990; 8(1):23-31. PubMed ID: 2198889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the biocompatibility of haemodialysis membranes.
    Hakim RM
    Nephrol Dial Transplant; 1995; 10 Suppl 10():7-11. PubMed ID: 8825426
    [No Abstract]   [Full Text] [Related]  

  • 20. Abdominal manifestations associated with use of a surface-treated AN69 membrane and ACEI during haemodialysis.
    Roux VD; Plaisance M
    Nephrol Dial Transplant; 2007 Jun; 22(6):1792-3. PubMed ID: 17314206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.